1213OCharacterization of complete responses (CRs) in...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1213OCharacterization of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO or IPI alone

Robert, C., Larkin, J., Ascierto, P.A., Long, G.V., Hassel, J.C., Schadendorf, D., Hodi, F.S., Lebbé, C., Grob, J-J., Grossmann, K., Wagstaff, J., Chesney, J., Hogg, D., Bechter, O., Márquez-Rodas, I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx377
Date:
September, 2017
File:
PDF, 100 KB
english, 2017
Conversion to is in progress
Conversion to is failed